101 related articles for article (PubMed ID: 7368655)
1. [Morphological characteristics of serous ovarian adenocarcinomas after chemotherapy].
Serov SF; Irzhanov SI
Vopr Onkol; 1980; 26(3):37-40. PubMed ID: 7368655
[TBL] [Abstract][Full Text] [Related]
2. [Mitotic activity changes in serous ovarian cystadenocarcinomas under treated with chemotherapy].
Irzhanov SI; Serov SF
Vopr Onkol; 1980; 26(10):60-3. PubMed ID: 6776688
[TBL] [Abstract][Full Text] [Related]
3. [Mitotic activity in ovarian serous cystadenocarcinomas treated with thio-TEPA].
Irzhanov SI
Akush Ginekol (Mosk); 1979 Dec; (12):38-9. PubMed ID: 119443
[No Abstract] [Full Text] [Related]
4. [Characteristics of the dissemination process in patients with serous cystadenocarcinoma of the ovaries].
Dzhilavian GA
Vopr Onkol; 1984; 30(8):83-6. PubMed ID: 6485289
[TBL] [Abstract][Full Text] [Related]
5. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.
Everett EN; French AE; Stone RL; Pastore LM; Jazaeri AA; Andersen WA; Taylor PT
Am J Obstet Gynecol; 2006 Aug; 195(2):568-74; discussion 574-6. PubMed ID: 16890558
[TBL] [Abstract][Full Text] [Related]
6. [The effect of various factors on the results of chemotherapy in patients with recurrent ovarian serous cystadenocarcinoma].
Dzhilavian GA; Vinokurov VL
Vopr Onkol; 1984; 30(3):16-21. PubMed ID: 6424327
[TBL] [Abstract][Full Text] [Related]
7. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant treatment of cystadenocarcinoma].
Héron JF
Rev Prat; 1989 Nov; 39(26):2325-8. PubMed ID: 2595223
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors and better survival rate after the treatment of advanced ovarian cancer with neoadjuvant chemotherapy].
Ivanov S; Ivanov S; Khadzhiolov N
Akush Ginekol (Sofiia); 2004; 43(6):17-9. PubMed ID: 15669647
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.
Schmeler KM; Sun CC; Bodurka DC; Deavers MT; Malpica A; Coleman RL; Ramirez PT; Gershenson DM
Gynecol Oncol; 2008 Mar; 108(3):510-4. PubMed ID: 18155273
[TBL] [Abstract][Full Text] [Related]
11. [Histological evaluation of cancer chemotherapy on rat ovarian cancer].
Nishida T
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1186-92. PubMed ID: 6540819
[TBL] [Abstract][Full Text] [Related]
12. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
Gershenson DM; Sun CC; Bodurka D; Coleman RL; Lu KH; Sood AK; Deavers M; Malpica AL; Kavanagh JJ
Gynecol Oncol; 2009 Jul; 114(1):48-52. PubMed ID: 19361839
[TBL] [Abstract][Full Text] [Related]
13. [Some cytological characteristics of serous cystomas of the ovaries].
Irzhanov SI
Arkh Anat Gistol Embriol; 1971 May; 60(5):103-8. PubMed ID: 5135780
[No Abstract] [Full Text] [Related]
14. Cystadenocarcinoma of the ovary in a 4-year-old: benign transformation during therapy.
Hong SJ; Lurain JR; Tsukada Y; Piver MS; Humbert JR; Freeman AI
Cancer; 1980 Apr; 45(8):2227-30. PubMed ID: 7370965
[TBL] [Abstract][Full Text] [Related]
15. [Prediction of the clinical response of ovarian cancer to chemotherapy using an in vitro anticancer drug sensitivity test].
Li ZX
Zhonghua Fu Chan Ke Za Zhi; 1988 Sep; 23(5):287-9, 318. PubMed ID: 3250811
[No Abstract] [Full Text] [Related]
16. [The silent killer: treatment of a patient by the oncological team].
Lindert AC; Barents JW; Pinedo HM
Ned Tijdschr Geneeskd; 1978 Jan; 122(3):65-8. PubMed ID: 622198
[No Abstract] [Full Text] [Related]
17. Characterization of a human ovarian carcinoma cell line: UCI 101.
Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY
Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy in advanced ovarian cancer.
Schein PS
Geriatrics; 1973 Dec; 28(12):89-95. PubMed ID: 4128004
[No Abstract] [Full Text] [Related]
19. [Comparative study of 2 combined chemotherapy protocols in the treatment of stage III-IV ovarian cancer patients].
Marenich AF; Perevodchikova NI; Grigorova TM; Pashkiavichus RI
Vestn Akad Med Nauk SSSR; 1980; (5):28-32. PubMed ID: 7395336
[No Abstract] [Full Text] [Related]
20. [Chemotherapy for ovarian cancer].
Lindell A
Lakartidningen; 1968 Mar; 65(11):1120-2. PubMed ID: 5743130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
